| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Sophia Genetics SA (SOPH) has 9 insiders with recent SEC Form 4 filings, including 0 buys and 17 sells. SOPH is classified in the Health Information Services industry within the Healthcare sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 3.71M | $20.24M | - | |
| Pres | 681.7K | $3.72M | - | |
| Other | 622.3K | $3.40M | -4,000 | |
| Other | 346.4K | $1.89M | - | |
| CFO | 297.8K | $1.63M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 15, 2026 | Xu Zhenyu | Chief Scientific Officer | Sell | 4,000 | $5.01 | $20,056.40 | -0.6% | - | - | |
| May 26, 2026 | Menu Philippe | Chief Medical Officer | Sell | 5,000 | $4.95 | $24,774.00 | -2.0% | - | - | |
| Apr 20, 2026 | Puylaert Kevin | Chief Sales Officer | Sell | 33 | $5.08 | $167.69 | - | - | - | |
| Apr 20, 2026 | Muken Ross | President | Sell | 760 | $5.20 | $3,954.96 | -0.1% | - | - | |
| Apr 13, 2026 | Camblong Jurgi | Chief Executive Officer | Sell | 16,631 | $4.73 | $78,667.85 | -0.1% | - | - | |
| Apr 13, 2026 | Xu Zhenyu | Chief Scientific Officer | Sell | 8,120 | $4.73 | $38,374.02 | -0.4% | - | - | |
| Apr 13, 2026 | Menu Philippe | Chief Medical Officer | Sell | 8,125 | $4.73 | $38,403.68 | -1.0% | - | - | |
| Apr 13, 2026 | Muken Ross | President | Sell | 8,129 | $4.73 | $38,444.89 | -0.6% | - | - | |
| Apr 10, 2026 | Van Well Daan | Chief Legal Officer | Sell | 2,400 | $4.67 | $11,201.28 | -0.7% | - | - | |
| Mar 31, 2026 | Puylaert Kevin | Chief Sales Officer | Sell | 3 | $4.71 | $14.13 | - | - | - |